Wisconsin Administrative Code › Department of Safety and Professional Services › SPS 1-299 - Professional Services › SPS 1-29 - Procedures, Miscellaneous › Chapter SPS 7 - Professional Assistance Procedure › Section SPS 7.11 - Approval of drug testing programs

Current through June 24, 2024
The department shall approve drug testing programs for use
					 by credential holders who participate in drug and alcohol monitoring programs
					 pursuant to agreements between the department or boards and credential holders,
					 or pursuant to disciplinary orders. To be approved as a drug testing program
					 for the department, programs shall satisfactorily meet all of the following
					 standards in the areas of program administration, collection site
					 administration, laboratory requirements and reporting requirements:
(1) Program administration requirements are:
(a) The program shall enroll participants by
				  setting up an account, establishing a method of payment and supplying
				  preprinted chain-of-custody forms.
(b) The program shall provide the participant
				  with the address and phone number of the nearest collection sites and shall
				  assist in locating a qualified collection site when traveling outside the local
				  area.
(c) Random selection of days
				  when participants shall provide specimens shall begin upon enrollment and the
				  program shall notify designated department staff that selection has
				  begun.
(d) The program shall
				  maintain a nationwide toll-free access or an internet website that is
				  operational 24 hours per day, 7 days per week to inform participants of when to
				  provide specimens and is able to document the date and time of contacts by
				  credential holders.
(e) The program
				  shall maintain and make available to the department and treatment providers
				  through an internet website data that are updated on a daily basis verifying
				  the date and time each participant was notified after random selection to
				  provide a specimen, the date, time and location each specimen was collected,
				  the results of drug screen and whether or not the participant complied as
				  directed.
(f) The program shall
				  maintain internal and external quality of test results and other
				  services.
(g) The program shall
				  maintain the confidentiality of participants in accordance with s.
				  146.82,
				  Stats.
(h) The program shall inform
				  participants of the total cost for each drug screen including the cost for
				  program administration, collection, transportation, analysis, reporting and
				  confirmation. Total cost shall not include the services of a medical review
				  officer.
(i) The program shall
				  immediately report to the department if the program, laboratory or any
				  collection site fails to comply with this section. The department may remove a
				  program from the approved list if the program fails to comply with this
				  section.
(j) The program shall make
				  available to the department experts to support a test result for 5 years after
				  the test results are released to the department.
(k) The program shall not sell or otherwise
				  transfer or transmit names and other personal identification information of the
				  participants to other persons or entities without permission from the
				  department. The program shall not solicit from participants presently or
				  formerly in the monitoring program or otherwise contact participants except for
				  purposes consistent with administering the program and only with permission
				  from the department.
(L) The
				  program and laboratory shall not disclose to the participant or the public the
				  specific drugs tested.